ArticleCancer gene therapy2024
GRIN2A mutation is a novel indicator of stratifying beneficiaries of immune checkpoint inhibitors in multiple cancers.
Gan-Xun Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it